Digoxin: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) No edit summary |
No edit summary |
||
| Line 17: | Line 17: | ||
'''| [[Digoxin dosage forms and strengths|Dosage Forms and Strengths]]''' | '''| [[Digoxin dosage forms and strengths|Dosage Forms and Strengths]]''' | ||
'''| [[Digoxin contraindications|Contraindications]]''' | '''| [[Digoxin contraindications|Contraindications]]''' | ||
'''| [[Digoxin warnings|Warnings and Precautions]]''' | '''| [[Digoxin warnings and precautions|Warnings and Precautions]]''' | ||
'''| [[Digoxin adverse reactions|Adverse Reactions]]''' | '''| [[Digoxin adverse reactions|Adverse Reactions]]''' | ||
'''| [[Digoxin drug interactions|Drug Interactions]]''' | '''| [[Digoxin drug interactions|Drug Interactions]]''' | ||
Revision as of 20:24, 22 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
For patient information, click here.
Overview
Category
US Brand Names
LANOXIN®, DIGOXIN®
FDA Package Insert
| Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages